Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20417857 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria Patients
Condition: Malaria
Interventions: Drug: Pyronaridine artesunate;   Drug: Coartem® (artemether lumefantrine)

Indicates status has not been verified in more than two years